Sucampo Pharma Revenue, Profits - SCMP Quarterly Income Statement

Add to My Stocks
$18 $0 (0%) SCMP stock closing price Feb 13, 2018 (Closing)

Financial analysis of Sucampo Pharma involves more than just checking the Sucampo Pharma stock price, by looking at the financial statements of the company in detail. In the income statement, an investor can check for important parameters like the topline or sales, the bottomline or profits, the basic EPS, dividends etc. The income statement is always for an accounting period, typically for a year or quarter, and affects the stock. In this case, the SCMP stock is bound to reflect the impact of the QOQ growth of 2.29%. One also needs to look at Sucampo Pharma assets, operating expenses and Sucampo Pharma free cash flow. The Sucampo Pharma profit and loss statement shows revenue of $61.27M for 2017 Q3. Revenue has grown by 2.29% QoQ for SCMP stock.

View and download details of revenue and profits for Sucampo Pharma for latest & last 40 quarters.
show more
Quarterly
Annual
View Previous Quarters
View Next Quarters
Fiscal year is Jan - Dec2017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q4
Sucampo Pharma Revenues or Net Sales
61.27M59.9M56.28M73.02M57.87M51.95M47.21M55.37M
Cost Of Goods Sold (COGS)17.43M17.03M16.88M16.74M15.58M20.35M23.33M18.08M
Sucampo Pharma Gross Profit
43.83M42.86M39.4M56.31M42.28M31.59M23.87M37.29M
Research & Development Expense10.13M205.7M10.33M11.04M9.97M10.93M14.67M11.36M
Selling General & Admin Expense12.49M12.99M18.2M11.78M19.04M13.04M9.7M14.38M
Income Before Depreciation Depletion Amortization21.2M-175.83M10.86M33.5M13.26M7.61M-0.5M11.57M
Depreciation Depletion Amortization--------
Non Operating Income-0.67M-0.47M--21.03M8.13M-2.52M-0.32M3.98M
Interest Expense2.95M2.91M2.89M5.63M5.89M5.97M6.27M6.08M
Sucampo Pharma Pretax Income
17.57M-179.22M8.2M6.84M15.5M-0.88M-7.09M9.47M
Provision for Income Taxes7.2M1.94M3.58M-8.44M7.41M-0.05M-3.03M-0.67M
MinorityInterest--------
Investment Gains Losses--------
Other Income--------
Income Before Extraordinaries & Disc Operations10.37M-181.17M4.62M15.28M8.09M-0.83M-4.06M10.15M
Extraordinary Items & Discontinued Operations--------
Sucampo Pharma Profit/ Loss (Net Income)
10.37M-181.17M4.62M15.28M8.09M-0.83M-4.06M10.15M
Average Shares used to compute Diluted EPS65.08M46.2M62.11M44.91M43.44M42.76M42.54M44.34M
Average Shares used to compute Basic EPS46.34M46.2M43.44M43.05M42.81M42.76M42.54M42.89M
Income Before Nonrecurring Items15.83M16.46M12.98M30.68M12.37M9.95M8.96M19.07M
Income from Nonrecurring Items-5.47M-197.63M-8.35M-15.4M-4.28M-10.78M-13.02M-8.92M
Sucampo Pharma Earnings Per Share Basic Net
0.22-3.920.110.360.19-0.02-0.100.24
Sucampo Pharma Earnings Per Share Diluted Net
0.19-3.920.100.340.19-0.02-0.100.23
EPS Diluted Before Nonrecurring Items0.270.280.230.680.280.230.210.44
Preferred Dividends Acc Pd--------
Dividends Common--------
Dividend Per Share Common0.000.000.000.000.000.000.000.00
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters

It is very helpful to read a report on Sucampo Pharma stock analysis. An investor must check the following items in an income statement:

  • Revenue: The money received by selling of goods or services comes under this line item. A QoQ growth - See: Sucampo Pharma revenue chart, implies that the company is growing. It has been the case with Sucampo Pharma. One must look at stocks with increasing revenues, and stay away from stocks whose revenues or sales are declining.
  • Bottom line: The bottomline or the net income figure is arrived at by deducting all expenses from the topline which in this case is $10.37M for SCMP stock. An improving bottomline implies that the company is growing its profits.

The income statement is also called statement of revenue and expense. The SCMP financials along with Sucampo Pharma historical stock prices provide a lot of details about the firm.

Sucampo Pharma Income Statement - Key Financial Ratios

PS Ratio (price sales ratio)
3.33
Operating Margin
34.6
Net Profit Margin
16.9
Dividend Yield
0%